Colistin for pneumonia involving multidrug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex.
CONCLUSIONS: IH colistin provided good outcomes with few side effects, and appropriate dosing of IV colistin was important to avoid excess mortality.
PMID: 31607573 [PubMed - as supplied by publisher]
Source: Journal of Microbiology, Immunology, and Infection - Category: Microbiology Authors: Zheng JY, Huang SS, Huang SH, Ye JJ Tags: J Microbiol Immunol Infect Source Type: research
More News: Acinetobacter | Allergy & Immunology | Microbiology | Multidrug Resistance | Physiology | Pneumonia | Study